We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PARIS, France, June 4, 2024 – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.16 | -1.21212121212 | 13.2 | 13.24 | 11.74 | 26463 | 12.36088033 | DE |
4 | -0.3 | -2.24887556222 | 13.34 | 13.58 | 11.74 | 18780 | 12.54648155 | DE |
12 | -0.16 | -1.21212121212 | 13.2 | 15.42 | 11.74 | 23989 | 13.54806306 | DE |
26 | 2.98 | 29.6222664016 | 10.06 | 15.42 | 9.35 | 30104 | 12.39976087 | DE |
52 | -2.96 | -18.5 | 16 | 19.18 | 7.89 | 36061 | 11.95339343 | DE |
156 | -16.46 | -55.7966101695 | 29.5 | 36.7 | 5.6 | 31977 | 13.95970404 | DE |
260 | 4.73 | 56.9193742479 | 8.31 | 39 | 5.6 | 32917 | 17.03278096 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions